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ABSTRACT
Objective: The present study was intended to evaluate the subchronic toxicity of Lactobacillus-mediated fermented Houttuynia cordata juice (FHJ) 
using rodent model system.
Methods: FHJ was prepared and the microbial load, lactic acid content, and pH was estimated. Rats were fed with different doses of FHJ for 60 days. 
The body mass changes were measured during FHJ supplementation. After the treatment period, blood and organs of the experimental rats were 
collected. The samples were subjected to hematological and biochemical analysis by following standard hospital protocols.
Results: The pH of FHJ after 30 days of fermentation was 3.63. The lactic acid content of FHJ was gradually increased and reached 19.70 mg per 
mL after 30 days of the fermentation process. Lactobacillus load was high in FHJ after 30 days and no Bacillus spp. and yeast were detected in 
FHJ at any point of fermentation. There were no significant changes in body weight of male and female experimental rats supplemented with FHJ, 
irrespective of dose. There were no significant treatment-related pathological changes found in any organ of the experimental rats at all tested dose 
levels when compared with organs in control animals. There were no significant changes observed in red blood cells (RBCs), white blood cells (WBCs), 
hemoglobin, hematocrits, lymphocyte, and platelets level of male rats of all groups. Whereas, significant (p<0.01) changes were observed in the 
RBC (1.02±0.26 106/mm3) of female rats in effective dose (ED) group compared to control. Similarly, significant (p<0.01) changes were detected in 
the WBC level of female rats in high dose (−7.53±0.03 103/mm3), and post-ED group (−8.86±0.75 103/mm3) compared to control. There were no 
alterations in tested biochemical parameters of experimental rats.
Conclusion: The FHJ was rich in probiotic Lactobacillus. The supplementation of FHJ (9 mL/kg/day) for 60 days did not significantly affect the body 
mass, internal organs, hematological, and biochemical parameters of rats. The results suggested that FHJ is qualified for the human consumption.
Keywords: Houttuynia cordata Thunb., Lactic acid bacteria, Fermented plant juice, Subchronic, Toxicity.
INTRODUCTION
Houttuynia cordata Thunb., known as Chinese lizard tail, heartleaf, 
chameleon plant, fish wort, and Khow Tong in Thai, is one of the 
known perennial herbs for the pharmacological benefits, comes 
under the family of Tutupalli and Chaubal [1,2]. Two chemotypes 
of H. cordata species are habited in Asian countries. The plant is 
native to Northeast India, Japan, Korea, southern China, Thailand, 
and Burma regions, and is frequently used by the local tribes for the 
therapeutic purposes and as a dietary vegetable [3]. H. cordata is 
rich in organic acids (linoleic, palmitic, and aspartic acids), volatile 
compounds (α-pinene, myrcene, d-limonene, decanoyl acetaldehyde, 
lauric aldehyde, and methyl nonyl ketone), flavonoids (hyperin, 
reyoutrin, quercetin, isoquercitrin, afzelin, and rutin), essential 
amino acids (alanine, arginine, aspartic acid, glutamic acid, glycine, 
histidine, isoleucine, leucine, lysine, methionine, phenylalanine, 
proline, serine, threonine, tyrosine, and valine), water-soluble 
polysaccharides, Vitamin-C, minerals, and trace elements (K, Fe, Zn, 
Cu, and Mn) [4].
H. cordata plant has been used to treat hyperglycemia, dysentery, 
cholera, and acute renal failure and to purify the circulating system [5,6]. 
The shoots of H. cordata are used as antidote and antivenom [2,7]. 
Several scientific reports revealed that H. cordata has a vast range 
of pharmacological effects such as anticancer (against leukemia), 
antileukemic, antioxidant, adjuvanticity, antimutagenic, anti-
inflammation, antibacterial, and antiviral (anti-HSV-1, anti-influenza, 
and anti-HIV-1) [4,8-13].
Fermented plant juices are famous among the people of Asian countries; 
especially, Thai people believe that consumption of traditionally 
prepared fermented plant juices has the supremacy to cure most of the 
illness [14]. The fermented foods are rich in bioactive microbes, which 
offer the health benefits to the consumer and improved the quality of the 
food [15]. The preparation of fermented plant-based food using specific 
starter culture improved the nutritional and pharmaceutical values of 
the food [16-18]. The fermented plant juice with bioactive principles 
can be an alternative food supplement with regular medication to 
control the metabolic disorders like diabetes [19].
Although H. cordata is used in several folk medicines to treat several 
diseases, the reports on fermented H. cordata juice (FHJ) are very 
limited. Kwon and Ha [20] reported that Bacillus spp. (isolated from 
the naturally fermented H. cordata) based fermentation increased 
the flavonoid content of the fermented H. cordata. The fermented 
H. cordata exhibited high protective effects against lipopolysaccharide 
(LPS)-induced inflammation with no cytotoxicity in RAW264.7 cells. 
Banjerdpongchai and Kongtawelert [21] stated that ethanolic extract 
of fermented H. cordata was strong toxic to human leukemic Molt-4 and 
HL-60 cells.
© 2018 The Authors. Published by Innovare Academic Sciences Pvt Ltd. This is an open access article under the CC BY license (http://creativecommons. 
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The subchronic toxicity studies are needed before any clinical trials. 
Thus, the present study was aimed to assess the subchronic toxicity of 
Lactobacillus-mediated fermented H. cordata using rodent model system.
METHODS
Preparation of fermented H. cordata thunb juice
H. cordata, water, and cane sugar were mixed in the ratio of 3:10:1 
and subjected to pasteurization. After sterilization and cooling of the 
medium, 10% of Lactobacillus paracasei HII03 was inoculated, and 
fermented for 30 days.
Physical observation of FHJ
The changes in the color, odor, and consistency of FHJ during and after 
fermentation were monitored by organoleptic techniques [22-24].
Determination of pH, lactic acid content, ethanol content, and 
microbial load
The experiments were performed as described in the previous studies. 
The pH of FHJ was kinetically assessed using pH meter (Inola, pH level 2, 
Weilheim) [16]. The lactic acid content of FHJ was determined by high-
performance liquid chromatography [25]. The gas chromatography 
method was employed to assess the ethanol content of FHJ [26]. The 
microbial load of FHJ was determined by spread plate method using 
specific media [27].
Animals, intervention, and sample collection
Sprague Dawley rats (150–180 g of weight) were purchased from 
National Laboratory Animal Center, Mahidol University, Thailand, and 
randomly divided into different groups as follows:
1. Control group: Standard laboratory foods (Commercial food no. 
C.P. 082, Perfect Companion Group Co., Ltd., Bangkok, Thailand) and 
water.
2. Low-dose group (effective dose [ED]): Standard laboratory foods 
and 1.2 mL/kg/day of FKJ.
3. High-dose group (HD): Standard laboratory foods and 9.0 mL/kg/day 
of FKJ.
4. Post-ED group (PED): Standard laboratory foods and 1.2 mL/kg/day 
of FKJ for 53 days (supplementation was stopped before 1 week 
of animal scarification and testing). The experimental rats were 
supplemented with test intervention for 60 days. After the 
intervention period, blood and internal organs were collected for 
examination. The experiments were ethically approved by the ethical 
committee of Faculty of Medicine, Chiang Mai University (Approved 
protocol no: 1/2552 dated 23 June 2009).
Measurement of body mass and Assessment of hematological and 
biochemical parameters
The changes in body mass of the experimental rats were measured using 
digital weighing balance. The difference in the weight was calculated as 
per the following formula:
Changes in body mass = Final weight – The initial weight of the 
experimental rat.
The weight of brain, eyes, heart, lung, liver, spleen, stomach, kidneys, and 
adrenal gland of the rat was measured. The hematological (hemoglobin, 
hematocrits, white blood cells (WBCs) count, lymphocyte, platelets, 
and red blood cells [RBCs] count), biochemical parameters for liver 
and kidney function (aminotransaminase, alanine aminotransaminase, 
alkaline phosphatase), and lipid profile (triglyceride and cholesterol) 
of the experimental rats were determined at MT InterMed (Hospital) 
Growth Diags. Co., Ltd., Chiang Mai, Thailand, as per the standard 
procedures.
Statistical analysis
The experiments were completed in triplicate. The values were 
signified as a mean ± standard deviation. Duncan’s new multiple range 
tests determined the significant differences, at the 95% confidential 
level (p<0.05) by SPSS v.17 (Chicago, SPSS Inc., U.S.A).
RESULTS AND DISCUSSION
The FHJ was prepared as detailed. The pH of FHJ was measured 
periodically and found that the pH was gradually reduced after 30 days 
of fermentation. The pH of FHJ after 30 days of fermentation was 3.63 
(Fig. 1a). The lactic acid content of FHJ was gradually increased and 
reached 19.70 mg per mL after 30 days of the fermentation process 
(Fig. 1b).
The microbial load in FHJ was estimated kinetically at different time 
points such as 3, 6, 10, 15, 20, and 30 days of fermentation. The 
total bacterial count (8.8–6.6 Log CFU/mL) and Lactobacillus spp. 
(8.64–6.4 Log CFU/mL) were gradually decreased over the period of 
fermentation. The reduction in bacterial load is possibly due to the 
high acidic condition and nutrient depletion in fermenting medium. At 
the end of the fermentation process, after 30 days, Lactobacillus spp. 
concentration was high (6.4 Log CFU/mL) in FHJ with respect to the 
total microbial load. Bacillus spp. and yeast were not found in FHJ at any 
point of fermentation, which suggested that FHJ was microbiologically 
safe (Fig. 2).
The changes in body mass of experimental rat were measured and 
tabulated (Table 1). The body mass increases in ED, HD, and PED group 
male rats were 175±24.32, 187±28.57, and 176±30.68 g, respectively, 
while control rat was 187.50±35.83 g. The body mass increases in 
ED, HD, and PED group female rats were 68.57±14.43, 62.14±17.99, 
and 63.57±13.97 g, respectively, while control rat was 75.83±18 g. 
There were no significant changes in body weight of male and female 
experimental rats supplemented with FHJ, irrespective of dose (ED, HD, 
and PED) (Table 1).
All the experimental rats were dissected after the study period to check 
macroscopic morphology of the organs. The organs brain, eyes, heart, 
lung, liver, spleen, stomach, kidneys, and adrenal gland were collected 
to determine the organ weight and physical changes. The changes in the 
organ weight, derived from the control animal, were reported (Table 2). 
There were no significant treatment-related pathological changes 
found in any organ of the experimental rats at all tested dose levels 
when compared with organs in control animals (Table 2).
The hematological changes in the experimental rats were determined. 
The differences, compared to representative control, were represented 
(Table 3). There were no significant changes observed in RBC, WBC, 
hemoglobin, hematocrits, lymphocyte, and platelets level of male rats 
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Table 1: The increase in body mass of test animals during the experimental period compared to baseline value
Duration (day) Body weight (g)
Male Female
Control ED* HD** PED*** Control ED HD PED
7 44.17±16.36 43.57±15.99 37.14±12.25 42.85±21.93 14.17±3.32 19.28±9.75 9.32±5.0 11.42±3.80
30 128.33±29.43 116.42±22.30 128.57±27.60 129.28±26.27 58.33±13.66 51.42±9.06 35.00±14.55 40.00±10.17
60 187.50±35.83 175.00±24.32 187.87±28.57 176.42±30.68 75.83±18.00 68.57±14.43 62.14±17.99 63.57±13.97
*ED: 1.2 ml/kg/day, **HD: 9 ml/kg/day, ***PED: Post-effective dose (intervention has been stopped before 7 days of final assessments), ED: Effective dose, HD: High 
dose
Table 2: Changes in the organ weight after oral supplementation of FHJ
Organs Weight (g)
Male Female
1.2 ml/kg/day (ED) 9 ml/kg/day (HD) PED 1.2 ml/kg/day (ED) 9 ml/kg/day (HD) PED
Brain −0.07±0.16 0.06±0.08 −0.13±0.49 0.1±0.11 0.12±0.06 0.12±0.05
Eyes 0±0.05 −0.04±0.06 0.03±0.01 0.07±0.05 0.03±0.06 0.1±0.01
Heart 0.03±0.37 0.06±0.36 0.48±0.29 0.01±0.18 0.17±0.45 0.6±0.19
Lung −0.37±0.22 −0.08±0.43 −0.29±0.14 −0.06±0.25 0.33±0.44 0.25±0.50
Liver 0.12±2.22 0.09±2.07 −1.31±1.01 1.1±0.07 0.7±0.88 0.6±0.01
Spleen −0.003±0.13 0.017±0.14 −0.113±0.05 0.07±0.06 0.11±0.06 0.01±0.03
Stomach −0.203±0.19 0.047±0.29 0.077±0.10 0.13±0.22 0.27±0.56 0.18±0.07
Kidneys −0.22±0.42 0.12±0.45 −0.14±0.43 0.27±0.24 0.14±0.18 0.1±0.13
Adrenal gland 0.004±0.00 0.029±0.05 0.014±0.01 0.02±0.02 0±0.02 0.016±0.02
The values were derived from the control values (the difference between control value and experimental value, after the experimental period) and were represented as a 
mean±standard deviation. ED: Effective dose, HD: High dose, PED: Post-effective dose, FHJ: Fermented Houttuynia cordata juice
Fig. 2: The microbial load in fermented Houttuynia cordata juice during fermentation
of all groups. Whereas, significant (p<0.01) changes were observed in 
the RBC (1.02±0.26 106/mm3) of female rats in ED group compared to 
control. Likewise, significant (p<0.01) changes were detected in the 
WBC level of female rats in HD (−7.53±0.03 103/mm3), and PED group 
(−8.86±0.75 103/mm3) compared to control (Table 3). There were no 
alterations in tested biochemical parameters (blood urea nitrogen, 
creatinine, cholesterol, triglyceride, aspartate aminotransferase, 
alanine aminotransferase, and alkaline phosphatase) of experimental 
rats, both male and female, of all treatment groups (Table 3). The 
results suggested that the consumption of FHJ, even HD, did not affect 
the internal organ of the experimental rats.
Several reports are available on the pharmacological importance of 
H. cordata extracts. The ethyl acetate extract of H. cordata (EAEH) has 
been reported for antiviral property against dengue virus and mouse 
hepatitis virus [28]. The EAEH exhibited hepatoprotective activity, 
inhibited the hydroxyl and alkyl free radicals in vitro, and prohibited the 
carbon tetrachloride-induced liver damage in mice [29], and the isolated 
alkaloids of H. cordata showed moderate hepatoprotective activity 
in d-galactosamine-induced WB-F344 cells, and anti-inflammatory 
activity [30,31].
The methanol extract of H. cordata induces apoptosis in human HepG2 
hepatocellular carcinoma cells through activation of hypoxia-inducible 
factor-1A - Forkhead box O3 and MEF2A pathways [32]. The ethanol 
extract of H. cordata persuades apoptosis in human leukemic Molt-
4 cells through endoplasmic reticulum stress pathway, which was 
characterized by declined expression of Bcl-xl and improved levels of 
Smac/Diablo, Bax, and GRP78 proteins [33]. Kumar et al. [2] reported that 
ethanolic extract of H. cordata (EEH) displayed the antidiabetic activity 
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in streptozotocin-induced diabetic rats. The oral supplementation of 
200–400 mg/kg body weight of EEH reduced the fasting glucose level, 
improved the insulin level, and normalized the biochemical parameters 
and the expression of glucose homeostatic enzyme-coding genes [2].
The ethanol extract of fermented H. cordata was reported for cytotoxicity 
effects in human leukemic HL-60 and Molt-4 cell. The apoptosis of 
cancer cell was achieved through activation and mitochondrial and 
oxidative stress pathway, and the study also suggested that fermented 
H. cordata was more toxic to human cancer cells than non-fermented 
H. cordata [21]. The fermented H. cordata protects the cells (RAW264.7 
and RBL-2H3) from LPS-induced toxicity and suppresses the growth 
of HepG2 cells (human liver cancer cells) [20]. Senawong et al. [34] 
studied the anticancer activity of commercially available fermented H. 
cordata products (CFH) of Thailand. About seven phenolic compounds 
were detected in CFH, and some of the CFH exhibited dose-dependent-
antiproliferative activity against HCT116, HT29, and HeLa cells.
An insufficient number of toxicity studies are there on H. cordata 
extracts and FHJ. The acute oral toxicity of EAEH was studied in 
C57BL/6 mice and found that 2000 mg/kg of EAEH supplementation 
did not cause any adverse behavioral and histopathological effects 
[28]. The ethanol extract of H. cordata leaves (EEHL) was studied for 
toxicity in F344/DuCrj rats. The supplementation of up to 5% of EEHL 
has not affected the hematological, ophthalmological parameters, and 
organs. The study reported that 1.5 and 0.5 % as dietary level of EEHL 
supplementation for male and female, respectively [35].
The results of the current study revealed that FHJ did not affected the 
behavioral character, body mass, internal organs, hematological, and 
biochemical parameters of experimental rats, and the consumption of FHJ 
was safe to rodent model system up to the concentration of 9 mL/Kg/day.
CONCLUSION
The FHJ was rich in probiotic Lactobacillus strain (L. paracasei HII03) 
and acidic in nature. The supplementation of FHJ (9 mL/Kg/day) for 
60 days did not significantly affect the body mass, internal organs, 
hematological, and biochemical parameters of rats. The results 
suggested that FHJ is eligible for the human consumption.
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